HCPLive

NOVEMBER 25, 2024

Hypovitaminosis D was more prevalent in patients with lupus nephritis compared to patients with systemic lupus erythematosus without kidney disease.

Kidney Disease 116

Kidney Disease 116

HCPLive

SEPTEMBER 18, 2024

The new guidance reviews existing tools for weight management and provides recommendations for their use in clinical practice in patients with obesity and kidney disease.

Kidney Disease 104

Kidney Disease Obesity 104

HCPLive

SEPTEMBER 20, 2024

Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.

Kidney Disease 105

Kidney Disease 105

HCPLive

MAY 17, 2024

Check out this quiz on the NKF's KDOQI recommendations on nutrition in chronic kidney disease, with a focus on their guidance for protein and energy intake!

Kidney Disease 104

Kidney Disease 104

Journal of Clinical Investigation - Cardiology

OCTOBER 1, 2024

of cases, a qualifying potentially disease-causing rare variant in an established gene was found.

Kidney Disease 112

Kidney Disease Research 112

HCPLive

FEBRUARY 2, 2024

Obesity was linked to an increased risk of focal segmental glomerulosclerosis and hypertensive nephropathy, with further analysis revealing its impact on the risk of developing end-stage kidney disease.

Kidney Disease 105

Kidney Disease Obesity Hypertension 105

HCPLive

JANUARY 23, 2024

Findings from the retrospective cohort study suggest an increased prevalence of advanced kidney disease among individuals with Crohn disease and ulcerative colitis.

Kidney Disease 105

Kidney Disease 105

HCPLive

APRIL 17, 2024

The consensus calls for the recognition of kidney disease as a major non-communicable disease driver of premature mortality by the World Health Organization.

Kidney Disease 98

Kidney Disease 98

Med Page Today

JANUARY 4, 2024

(MedPage Today) -- SGLT2 inhibitors significantly lowered the risk of death, major adverse kidney events (MAKE), and major adverse cardiovascular events (MACE) in people with type 2 diabetes and acute kidney disease, according to a cohort study.

Kidney Disease 104

Kidney Disease Diabetes 104

HCPLive

DECEMBER 14, 2023

Microbiota-based interventions may be a novel strategy to benefit the mitigation of chronic kidney disease advancement.

Kidney Disease 98

Kidney Disease 98

Frontiers in Cardiovascular Medicine

FEBRUARY 25, 2025

Research objectiveThis study is based on bioinformatics analysis to explore the co-expressed differentially expressed genes (DEGs) between atrial fibrillation (AF) and chronic kidney disease (CKD), identify the biomarkers for the occurrence and development of the two diseases, investigate the potential connections between AF and CKD, and explore the (..)

Kidney Disease 52

Kidney Disease Atrial Fibrillation Biomarkers Download 52

Journal of Clinical Investigation - Cardiology

MARCH 1, 2024

Two coding variants of apolipoprotein L1 (APOL1), called G1 and G2, explain much of the excess risk of kidney disease in African Americans. While various cytotoxic phenotypes have been reported in experimental models, the proximal mechanism by which G1 and G2 cause kidney disease is poorly understood.

Kidney Disease 98

Kidney Disease 98

HCPLive

JANUARY 4, 2024

Compared to nonusers, patients with type 2 diabetes and acute kidney disease administered SGLT-2is had a significantly lower risk of mortality, major adverse kidney events, and major adverse cardiovascular events.

Kidney Disease 104

Kidney Disease Diabetes 104

American Heart News - Heart News

MARCH 21, 2024

Research Highlights: A study of nearly 4 million young adults under age 40 in South Korea found that those who had ideal cardiovascular health were nearly two-thirds less likely to develop heart disease, stroke and/or kidney disease during a 12-year.

Kidney Disease 104

Kidney Disease Heart Disease Stroke Strokes 104

HeartRhythm

FEBRUARY 6, 2025

Limited evidence supports apixaban's use for atrial fibrillation (Af) in severe chronic kidney disease (CKD) or end-stage kidney disease (ESKD) patients, where warfarin is often contraindicated.

Kidney Disease 74

Kidney Disease Atrial Fibrillation 74

Med Page Today

FEBRUARY 14, 2025

(MedPage Today) -- The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular risk factors, a prespecified.

Kidney Disease 83

Kidney Disease Heart Attack Heart attacks Diabetes 83

American Heart News - Heart News

MARCH 24, 2025

DALLAS, March 24, 2025 Globally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics published by the American Heart Association, a global force changing the future of health for all. The rise in.

Kidney Disease 62

Kidney Disease 62

HCPLive

JANUARY 28, 2025

The FDA approved semaglutide to reduce the risk of kidney disease worsening, kidney failure, and death due to CVD in those with T2D and CKD.

Kidney Disease 75

Kidney Disease Diabetes 75

Medical Xpress - Cardiology

DECEMBER 19, 2023

Heart failure is causally associated with chronic kidney disease (CKD), according to a study published online Dec. 11 in PLOS ONE.

Kidney Disease 75

Kidney Disease Heart Failure 75

Journal of Clinical Investigation - Cardiology

FEBRUARY 15, 2024

Worldwide, over 800 million people are affected by kidney disease, yet its pathogenesis remains elusive, hindering the development of novel therapeutics. Lipid accumulation and the expression of genes related to DNL were elevated in the kidneys of patients with fibrosis.

Kidney Disease 78

Kidney Disease Pharmacology Ablation 78

HCPLive

MAY 20, 2024

A numerically slower decline in eGFR was reported in the finerenone cohort after hospitalization for heart failure when compared with placebo.

Heart Failure 116

Heart Failure Kidney Disease Hospital 116

HCPLive

MAY 29, 2024

Brendon Neuen, MBBS, PhD, joins the podcast to discuss the latest updates in nephrology, including the landmark FLOW trial.

Kidney Disease 135

Kidney Disease 135

HCPLive

OCTOBER 26, 2024

The dapagliflozin group had an average eGFR rate of -2.24 mL/min/1.73 m2 compared to -3.67 mL/min/1.73 m2 in the control group after about 1.5 years of follow-up.

Kidney Disease 111

Kidney Disease 111

HCPLive

JULY 25, 2024

The sNDA for furosemide seeks to expand the indication to include the treatment of edema due to fluid overload in patients with CKD, with a PDUFA date of March 6, 2025.

Kidney Disease 111

Kidney Disease 111

Cardiovascular Diabetology

FEBRUARY 14, 2025

People living with diabetes mellitus (DM) and chronic kidney disease (CKD) are at significantly high risk of cardiovascular events (CVEs), however the predictive performance of traditional risk prediction meth.

Kidney Disease 76

Kidney Disease Diabetes Research 76

HCPLive

MAY 27, 2024

An analysis of more than 800 IgAN patients treated from 2002-2021 provides an overview of factors associated with anmeia as well as its impact on pgronosis.

Kidney Disease 111

Kidney Disease 111

HCPLive

JULY 23, 2024

Spigler provides insight into the development of new patient-focused guidelines for managing hyperkalemia in CKD and the importance of providing patients with such resources.

Kidney Disease 111

Kidney Disease Education 111

Medical Xpress - Cardiology

MARCH 7, 2025

Patients with chronic kidney disease (CKD) and heart failure have higher rates of inpatient dialysis initiation than those without heart failure, according to a study published online Feb. 18 in Mayo Clinic Proceedings.

Kidney Disease 59

Kidney Disease Inpatient Heart Failure 59

HCPLive

NOVEMBER 13, 2024

People with diabetes, kidney stones, damaged joints, high uric acids, and daily use of NSAID were more likely to develop CKD than others.

Kidney Disease 105

Kidney Disease Diabetes 105

Journal of Clinical Investigation - Cardiology

FEBRUARY 15, 2024

Ten percent of the population worldwide suffers from chronic kidney disease (CKD), but the mechanisms driving CKD pathology are incompletely understood. Identify acyl-CoA synthetase short-chain family 2 (ACSS2) as a disease risk gene and demonstrate a role for ACSS2 in de novo lipogenesis (DNL).

Kidney Disease 64

Kidney Disease Pharmacology 64

Cardiovascular Diabetology

MARCH 21, 2025

Mineralocorticoid receptor antagonists (MRAs) are often underutilized in patients with heart failure (HF), particularly those with diabetes and/or chronic kidney disease (CKD). However, the impact of concurren.

Kidney Disease 59

Kidney Disease Heart Failure Diabetes Hospital 59

HCPLive

MARCH 26, 2024

A study in China identified a negative and non-linear relationship between hemoglobin levels and a renal composite end point in patients with DKD.

Kidney Disease 98

Kidney Disease Diabetes Outcomes 98

HCPLive

MARCH 6, 2025

In part 2 of this episode of Crisis Point, 3 nephrology experts and a patient advocate discuss strategies to address the CKD crisis.

Kidney Disease 82

Kidney Disease 82

HCPLive

FEBRUARY 12, 2025

In the final segments of this 4-part episode, the discussion focuses on the use of HCEs in different kidney disease trials.

Kidney Disease 59

Kidney Disease 59

HCPLive

DECEMBER 21, 2023

A new study is raising awareness around the effects of structural racism on the prevalence of chronic health conditions.

Kidney Disease 122

Kidney Disease Cardiovascular Disease Diabetes 122

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundInhibition of prostaglandin synthesis by nonsteroidal anti‐inflammatory drugs is associated with cardiovascular mortality and kidney disease. Future studies should address whether these associations are causal and can be targeted to improve cardiovascular and kidney outcomes.

Kidney Disease 73

Kidney Disease Risk Factors Outcomes Diabetes 73

HCPLive

MAY 18, 2024

Wei Ling Lau, MD, explains the importance of medication adherence to maximize the benefits of RAASi therapy.

Kidney Disease 115

Kidney Disease 115